PT  - JOURNAL ARTICLE
AU  - Jefsen, Oskar Hougaard
AU  - Speed, Maria
AU  - Friston, Karl John
AU  - Østergaard, Søren Dinesen
AU  - Speed, Doug
TI  - White matter disruption as a cause or consequence of schizophrenia: A Mendelian randomization study
AID  - 10.1101/2021.08.23.21262451
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.08.23.21262451
4099  - http://medrxiv.org/content/early/2021/08/26/2021.08.23.21262451.short
4100  - http://medrxiv.org/content/early/2021/08/26/2021.08.23.21262451.full
AB  - Schizophrenia is hypothesized to be caused by impaired functional integration in the brain, and this could hypothetically be caused by white matter disruptions, synaptic dysfunction, or both. Neuroimaging studies consistently show reduced fractional anisotropy, a measure of white matter integrity, in patients with schizophrenia. Using Mendelian randomization, we show that these white matter changes are likely to be the consequence of a primary synaptopathy in schizophrenia.Competing Interest StatementS.D.O. has received the 2020 Lundbeck Foundation Young Investigator Prize. Furthermore, S.D.O. owns units of mutual funds with stock tickers DKIGI and WEKAFKI. The remaining authors declare no competing interests.Funding StatementO.H.J. is supported by a grant from the Health Research Foundation of Central Denmark Region. D.S. is supported by Aarhus University Research Foundation (AUFF), by the Independent Research Fund Denmark under Project no. 7025-00094B, and by a Lundbeck Foundation Experiment Grant.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicable as the study was based on publicly available datasets.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNot applicable.